Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | THPO | P40225 | 1/20 | 0.56 |
| ▸ | MTOR | P42345 | 1/20 | 0.56 |
| ▸ | RORC | P51449 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28778645 | 0.81 | CXCR2 (0.63) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL28046110 | 0.80 | KMT2A (0.66) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL28158296 | 0.80 | KMT2A (0.70) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL358199 | 0.77 | ALDH1A1 (0.65) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL7691380 | 0.77 | CYP3A4 (0.65) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL8458244 | 0.76 | MEN1 (0.52) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL28158256 | 0.75 | MEN1 (0.60) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL1455286 | 0.75 | KMT2A (0.90) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL359543 | 0.75 | MEN1 (0.72) | MEN1KMT2AMAPTLMNACYP3A4 | |
| SCHEMBL27782904 | 0.75 | KDM1A (0.64) | MEN1KMT2AMAPTLMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200276140-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2020-09-03 | — | — | US | disclosed |
| EP-1401771-B1 | METHOD AND PLANT FOR CONTROLLING THE COLONIZATION OF SUBMERGED STRUCTURE SURFACES BY AQUATIC FILTERING ORGANISMS | CHIMEC SPA (IT) | 2006-06-07 | — | — | EP | disclosed |
| EP-0682474-B1 | A METHOD FOR CONTROLLING MACROINVERTEBRATES | BUCKMAN LABOR INC (US) | 1999-04-14 | — | — | EP | disclosed |
| US-5380762-A | In aqueous systems, adding ethylenediamine dihydroiodide | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1995-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200276140-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | MEN1 3451/4885KMT2A 3619/4885MAPT 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.